We performed propensity-matched cohort studies determining the risk to develop cardiac and vascular diseases (ICD10CM:I00-99) following diagnosis of CLE, DLE, or SCLE. Patients with systemic lupus erythematosus were excluded. We document that CLE and its subtype DLE but less so SCLE are ...
We used DDI corpus training data to build the machine learning workflow on classifying DDIs and ADR types. First, we classified the sentences with potential DDI information, then we classified DDIs to four ADR types. The 10-fold cross validation on classifying the sentences with potential DDI i...
syndrome/subacute cutaneous lupus erythematosus will occur in this setting and be difficult to differentiate but should be differentiated by SSA antibody positivity and/or direct immunofluorescence testing. Progressive immunotherapy-related mucocutaneous eruption (PIRME) has been named a distinct severe reactio...
The short-term probability of receiving an additional diagnosis of systemic lupus erythematosus (SLE) is also assessed.Methods A population-based open cohort study including all patients with CLE [International Classification of Diseases (ICD) code, ICD-10: L93] in Sweden, 2005鈥 2007. Patients (...
Cutaneous lupus erythematosus (CLE) is an autoimmune condition characterized by a wide range of clinical manifestations and limited treatment options. There is little research on the impact of commonly used diagnostic tests including antinuclear antibodies (ANA) and extractable nuclear antigens (ENA) on...
For comparison, the SLE cohort was identified by patients aged 18 years and older with primary or secondary diagnoses of SLE using ICD-10 codes. Chi-squared testwas used to compare baseline demographic characteristics. Multivariable logistic and linear regression was used to calculate outcomes of ...
Within this population, we identified adults with CLE, SLE, and psoriasis based on the following International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis codes: CLE using L93, SLE using M32, and psoriasis using L40. CLE was further classified by ...
(ICD-10). In hospitals where codification of diagnosis was incomplete or unavailable for the whole or parts of the period of analysis, the listing of cases was complemented by searching skin/mucosa samples in whichLeishmaniaDNA was detected by PCR and cytology, as well as histopathology reports ...
Recent studies found that the lncRNAs exert an important role in regulating the immune system by modifying gene expression in diverse inflammatory diseases such as systemic lupus erythematosus, rheumatoid arthritis and psoriasis [142–144]. The expression of lncRNA gene PRINS was elevated in the non...